Table 2.
Antagonist |
Inhibition of GH release, % |
|||||
---|---|---|---|---|---|---|
No. | Code no. | 0 min | 30 min | 60 min | 90 min | 120 min |
Standard antagonist* | 52 | 13 | 0 | 0 | 0 | |
1 | MZ-J-7-50 | 80 | 87 | 85 | 79 | 69 |
2 | MZ-J-7-52 | 48 | 39 | 44 | 30 | 22 |
3 | MZ-J-7-46 | 95 | 100 | 98 | 92 | 60 |
4 | MZ-J-7-48 | 78 | 80 | 77 | 74 | 73 |
5 | MZ-J-7-42 | 53 | 78 | 88 | 85 | 80 |
6 | MZ-J-7-44 | 85 | 82 | 86 | 76 | 66 |
7 | MZ-J-7-34 | 73 | 69 | 53 | 56 | 60 |
8 | MZ-J-7-38 | 53 | 57 | 34 | 37 | 45 |
9 | MZ-J-7-26 | 40 | 70 | 64 | 65 | 56 |
10 | MZ-J-7-30 | 87 | 84 | 70 | 64 | 65 |
11 | MZ-J-7-18 | 64 | 70 | 65 | 49 | 57 |
12 | MZ-J-7-22 | 13 | 23 | 24 | 29 | 27 |
13 | MZ-J-7-54 | 60 | 32 | 22 | 27 | 39 |
14 | MZ-J-7-56 | 75 | 49 | 32 | 27 | 39 |
15 | MZ-J-7-62 | 79 | 30 | 39 | 24 | 36 |
16 | MZ-J-7–64 | 38 | 36 | 34 | 18 | 26 |
17 | MZ-J-7-102 | 96 | 80 | 63 | 54 | 50 |
18 | MZ-J-7-112 | 58 | 83 | 73 | 56 | 56 |
19 | MZ-J-7-114 | 63 | 65 | 71 | 60 | 53 |
20 | MZ-J-7-116 | 72 | 64 | 46 | 53 | 44 |
21 | MZ-J-7-110 | 76 | 75 | 64 | 48 | 63 |
22 | JV-1-36* | 64 | 79 | 75 | 71 | 71 |
23 | JV-1-65* | 72 | 85 | 82 | 80 | 77 |
The antagonists were applied at a 30 nM concentration, except for the standard antagonist, which was applied at 100 nM.
Asterisks indicate data taken from ref. 18.